Riskpilot← Back to searchSign inGet full accessAlveon Labs AB
ABActiveOrg 5569744401Manufacture of electrical and electronic equipment for motor vehicles · NACE 2931Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
+92% vs 2024
Equity ratio
96.1%
Financial strength
Net profit 2025
SEK -2K
+92% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +92% |
| Net profit | SEK -2K | +92% |
| Total assets | SEK 68K | -2% |
| Equity | SEK 65K | -3% |
| Employees | 0 | — |
Legal name
Alveon Labs AB
Org number
5569744401
Legal form
Aktiebolag
NACE code
2931 · Manufacture of electrical and electronic equipment for motor vehicles
Founded
13 juni 2014
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva forskning, tillverkning och reparation av produkter och anläggningar för medicinsk, kemisk och mekanisk industri samt byggnadssektorn, vidare syssla företagsservice inom ekonomi samt allmänna konsulttjänster inom främst företagsledning och dataområdena, samt äga och förvalta fastigheter och värdehandlingar, ävensom idka annan därmed förenlig verksamhet.
Address
Email
engelhardtfilip@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −9 | −1 | −19 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −3 | −9 | −1 | −19 | −2 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | −3 | −9 | −1 | −19 | −2 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | −3 | −9 | −1 | −19 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 69 | 64 | 66 | 69 | 68 |
| Equity | 69 | 65 | 63 | 67 | 65 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 0 | 0 | 3 | 3 | 3 |
| Total debt | — | — | 3 | 3 | 3 |
EBITDA margin
-155000.0%
This company
15.8%
Market median
-981113% vs market
20212025
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
-2.4%
This company
18.4%
Market median
-113% vs market
20212025
Net profit margin
-154600.0%
This company
8.1%
Market median
-1908742% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (3) | ||
| Chairman | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alveon Labs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Filip Hampus Engelhardt | Board of Directors | 0 companies |
| Walter Karl Engelhardt | Chairman | 0 companies |
| Lars Johan Nilsson Friberg | Board of Directors | 0 companies |
| Leif Torbjörn Wrenkler | Board of Directors | 0 companies |
| Karl Felix Engelhardt | Deputy Board Member | 0 companies |